Document is current
Any future updates will be listed below
-
Authors
Hughes, Michael https://orcid.org/0000-0003-3361-4909
Jude, Edward https://orcid.org/0000-0002-3186-4122
McMahan, Zsuzsanna H.
Alam, Uazman https://orcid.org/0000-0002-3190-1122
Ruaro, Barbara https://orcid.org/0000-0001-8990-859X
Zhao, Sizheng Steven https://orcid.org/0000-0002-3558-7353
- License Information
-
More Information
Article History
Received: 23 December 2025
Revised: 17 January 2026
Accepted: 19 January 2026
First Online: 29 January 2026
Declarations
:
: MH reports Research Funding and Speaker Fees from Janssen; Conference Support from UCB; and Consultancy Fees from Boehringer Ingelheim and Novartis (none of which are relevant to this manuscript). UA has no direct COI. However, UA declares that he has received honoraria from Viatris, Grünenthal, Eli Lilly, Procter & Gamble, and for educational meetings and has received investigator-led funding from Procter & Gamble. UA has received sponsorship to educational meetings from Daiichi Sankyo and Sanofi. None of the other authors report any relevant disclosures to the manuscript.
